Dublin, July 26, 2023 (GLOBE NEWSWIRE) -- The "Testosterone Replacement Therapy Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.
This report provides strategists, marketers, and senior management with critical information needed to assess the Testosterone Replacement Therapy market. The market is projected to grow from $1.75 billion in 2022 to $1.85 billion in 2023, with a compound annual growth rate (CAGR) of 5.4%. Furthermore, the market is expected to reach $2.22 billion by 2027, with a CAGR of 4.6%.
Major players in the Testosterone Replacement Therapy market include AbbVie Inc., Acerus Pharmaceuticals Corporation, Antares Pharma Inc., Bayer AG, BioTE Medical LLC, Clarus Therapeutics, Eli Lilly and Company, Endo Pharmaceuticals, Pfizer Inc., Teva Pharmaceutical Industries, Acrux Limited, Actiza Pharmaceutical, Aytu BioPharma, Cipla Limited, Sun Pharmaceutical Industries Limited, The Simple Pharma Company UK Limited, and Ferring Pharmaceuticals.
Reasons to Purchase:
- Gain a comprehensive global perspective with detailed coverage of 50+ geographies.
- Understand the market's response to COVID-19 and how it is responding as the impact of the virus abates.
- Assess the direct and indirect effects of the Russia-Ukraine war on agriculture, energy, mineral commodity supply, and the market.
- Measure the influence of high global inflation on market growth.
- Develop regional and country-specific strategies based on localized data and analysis.
- Identify investment opportunities in growth segments.
- Outperform competitors using forecast data and insights into market drivers and trends.
- Understand customer dynamics based on the latest market shares.
- Benchmark performance against key competitors.
- Support internal and external presentations with reliable high-quality data and analysis.
Testosterone Replacement Therapy is a hormonal therapy used to treat low testosterone (T) levels in males, which can occur due to aging or a medical condition.
The main types of testosterone replacement therapy include oral, implants, gel or creams, patches, buccal adhesive, parenteral, and others. Oral administration involves taking substances through the mouth, such as tablets, capsules, and syrups. Major indications for low testosterone are hypogonadism, autoimmune conditions, genetic disorders, sex organ surgeries, and others, treated with various active ingredients such as testosterone, methyl testosterone, testosterone undecanoate, testosterone enanthate, and testosterone cypionate, used by end users like hospitals, clinics, and others.
Product innovation has emerged as a key trend in the testosterone replacement therapy market, with major companies developing innovative products to strengthen their position.
In October 2022, Tolmar Pharmaceuticals Inc. acquired Clarus Therapeutics Inc. to strengthen its portfolio in urology and men's health by adding JATENZO, a testosterone replacement therapy. Clarus Therapeutics Inc. is a US-based company operating in testosterone replacement therapy.
North America was the largest region in the testosterone replacement therapy market in 2022, while Asia-Pacific is expected to experience significant growth in the forecast period. The regions covered in the report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. Key countries analyzed in the report include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.
The rising testosterone deficiency is expected to drive the growth of the testosterone replacement therapy market, with the therapy used to raise testosterone levels and treat symptoms such as reduced libido, erectile dysfunction, depressed mood, anemia, and loss of muscle.
For instance, approximately 13 million men in the United States suffer from low testosterone levels, accounting for 1 in 4 males over the age of 30. As a result, the rise in testosterone deficiency is driving the growth of the testosterone replacement therapy market.
The testosterone replacement therapy market includes revenues earned by entities providing hormone testing, semen analysis, pituitary imaging, genetic studies, and testicular biopsy to treat low testosterone deficiency. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 250 |
| Forecast Period | 2023 - 2027 |
| Estimated Market Value (USD) in 2023 | $1.85 billion |
| Forecasted Market Value (USD) by 2027 | $2.22 billion |
| Compound Annual Growth Rate | 4.7% |
| Regions Covered | Global |
Key Topics Covered:
1. Executive Summary
2. Testosterone Replacement Therapy Market Characteristics
3. Testosterone Replacement Therapy Market Trends And Strategies
4. Testosterone Replacement Therapy Market - Macro Economic Scenario
4.1. COVID-19 Impact On Testosterone Replacement Therapy Market
4.2. Ukraine-Russia War Impact On Testosterone Replacement Therapy Market
4.3. Impact Of High Inflation On Testosterone Replacement Therapy Market
5. Testosterone Replacement Therapy Market Size And Growth
5.1. Global Testosterone Replacement Therapy Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Testosterone Replacement Therapy Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Testosterone Replacement Therapy Market Segmentation
6.1. Global Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Oral
- Implants
- Gel Or Creams
- Patches
- Buccal Adhesive
- Parenteral
- Other Products
6.2. Global Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Hypogonadism
- Autoimmune Conditions
- Genetic Disorders
- Sex Organ Surgeries
- Other Indications
6.3. Global Testosterone Replacement Therapy Market, Segmentation By Active Ingredient Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Testosterone
- Methyl Testosterone
- Testosterone Undecanoate
- Testosterone Enanthate
- Testosterone Cypionate
6.4. Global Testosterone Replacement Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Hospitals
- Clinics
- Other End-User
7. Testosterone Replacement Therapy Market Regional And Country Analysis
7.1. Global Testosterone Replacement Therapy Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Testosterone Replacement Therapy Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
For more information about this report visit https://www.researchandmarkets.com/r/fj3ca7
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
